Sept 5 (Reuters) - Biogen Inc BIIB.O
* Forward pharma a/s says filing in a u.s. Court of opening
brief for appeal of a ptab decision
* Forward pharma - the ptab decision ended interference
proceeding between forward's 11/576,871 patent application and
an issued biogen patent
* Forward pharma - after biogen files its responsive brief,
currently due oct 16, 2017, forward is allowed a reply brief,
currently due october 30, 2017
* Forward pharma a/s - an oral argument is expected to be
held before the federal circuit in late 2017 or early 2018
Source text for Eikon: ID:nGNXOEAUSa
Further company coverage: BIIB.O
(Bengaluru Newsroom: +1 646 223 8780)